Arquer Dx Developing Urine-Based Protein Biomarker Tests to Detect Bladder, Endometrial Cancers
360Dx,
NEW YORK ─ Arquer Diagnostics is developing urine-based assays that it believes have the potential to improve health outcomes…
NEW YORK ─ Arquer Diagnostics is developing urine-based assays that it believes have the potential to improve health outcomes…
Endometrial adenocarcinoma, light micrograph. Arquer Diagnostics is developing non-invasive tests for diagnosing and monitoring…
New research adds to wealth of existing data for ADX portfolio of cancer diagnostics SUNDERLAND, United Kingdom, Feb.
New research adds to wealth of existing data for ADX portfolio of cancer diagnostics SUNDERLAND, United Kingdom, Feb.